Fujian Aonong Biological Technology Group Incorporation Limited reported earnings results for the nine months ended September 30, 2022. For the nine months, the company reported sales was CNY 15,402.56 million compared to CNY 13,322.02 million a year ago. Revenue was CNY 15,402.56 million compared to CNY 13,322.02 million a year ago.

Net loss was CNY 572.71 million compared to CNY 502.87 million a year ago. Basic loss per share from continuing operations was CNY 0.76 compared to CNY 0.78 a year ago.